Advances in CAR T cell immunotherapy for paediatric brain tumours
- Author(s)
- Rao, P; Furst, L; Meyran, D; Mayoh, C; Neeson, PJ; Terry, R; Khuong-Quang, DA; Mantamadiotis, T; Ekert, PG;
- Journal Title
- Frontiers in Oncology
- Publication Type
- Review
- Abstract
- Brain tumours are the most common solid tumour in children and the leading cause of cancer related death in children. Current treatments include surgery, chemotherapy and radiotherapy. The need for aggressive treatment means many survivors are left with permanent severe disability, physical, intellectual and social. Recent progress in immunotherapy, including genetically engineered T cells with chimeric antigen receptors (CARs) for treating cancer, may provide new avenues to improved outcomes for patients with paediatric brain cancer. In this review we discuss advances in CAR T cell immunotherapy, the major CAR T cell targets that are in clinical and pre-clinical development with a focus on paediatric brain tumours, the paediatric brain tumour microenvironment and strategies used to improve CAR T cell therapy for paediatric tumours.
- Keywords
- CAR T cell; blood brain barrier; immunotherapy; paediatric brain tumour; tumour microenvironment
- Department(s)
- Laboratory Research
- PubMed ID
- 36505819
- Publisher's Version
- https://doi.org/10.3389/fonc.2022.873722
- Open Access at Publisher's Site
https://doi.org/10.3389/fonc.2022.873722- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2025-03-07 02:36:23
Last Modified: 2025-03-07 02:38:23